GHRS
Price
$14.89
Change
+$0.40 (+2.76%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
929.2M
22 days until earnings call
ORMP
Price
$2.23
Change
+$0.07 (+3.24%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
90.27M
15 days until earnings call
Interact to see
Advertisement

GHRS vs ORMP

Header iconGHRS vs ORMP Comparison
Open Charts GHRS vs ORMPBanner chart's image
GH Research
Price$14.89
Change+$0.40 (+2.76%)
Volume$11.74K
Capitalization929.2M
Oramed Pharmaceuticals
Price$2.23
Change+$0.07 (+3.24%)
Volume$100
Capitalization90.27M
GHRS vs ORMP Comparison Chart in %
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. ORMP commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and ORMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (GHRS: $14.50 vs. ORMP: $2.21)
Brand notoriety: GHRS and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 127% vs. ORMP: 84%
Market capitalization -- GHRS: $899.43M vs. ORMP: $90.27M
GHRS [@Biotechnology] is valued at $899.43M. ORMP’s [@Biotechnology] market capitalization is $90.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, GHRS is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • GHRS’s TA Score: 3 bullish, 5 bearish.
  • ORMP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than GHRS.

Price Growth

GHRS (@Biotechnology) experienced а -17.47% price change this week, while ORMP (@Biotechnology) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.74%. For the same industry, the average monthly price growth was +20.88%, and the average quarterly price growth was +48.02%.

Reported Earning Dates

GHRS is expected to report earnings on Nov 06, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+6.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($929M) has a higher market cap than ORMP($90.3M). GHRS YTD gains are higher at: 114.000 vs. ORMP (-8.678). ORMP has higher annual earnings (EBITDA): -21.53M vs. GHRS (-41.75M). GHRS has more cash in the bank: 291M vs. ORMP (131M). ORMP has less debt than GHRS: ORMP (301K) vs GHRS (658K). ORMP has higher revenues than GHRS: ORMP (2M) vs GHRS (0).
GHRSORMPGHRS / ORMP
Capitalization929M90.3M1,029%
EBITDA-41.75M-21.53M194%
Gain YTD114.000-8.678-1,314%
P/E RatioN/A20.91-
Revenue02M-
Total Cash291M131M222%
Total Debt658K301K219%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSORMP
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHMX5.43N/A
N/A
Next-ChemX Corporation
FAXXF17.80N/A
N/A
Fairfax Financial Holdings Ltd.
NCAUF0.42-0.01
-1.53%
Newcore Gold Ltd.
SOUHY9.73-0.20
-2.01%
South32 Ltd.
DELKY20.52-0.98
-4.56%
Delek Group Ltd.

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
+3.31%
MDGL - GHRS
43%
Loosely correlated
-1.42%
IVVD - GHRS
39%
Loosely correlated
+6.66%
ATAI - GHRS
35%
Loosely correlated
-6.72%
IBRX - GHRS
31%
Poorly correlated
-7.34%
ORMP - GHRS
31%
Poorly correlated
-1.34%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.34%
BTAI - ORMP
44%
Loosely correlated
-6.08%
INO - ORMP
44%
Loosely correlated
+0.68%
MBIO - ORMP
44%
Loosely correlated
-0.52%
VERV - ORMP
44%
Loosely correlated
N/A
ZNTL - ORMP
43%
Loosely correlated
-2.04%
More